title: The Long and Short of Tamoxifen Therapy: A Review of the ATLAS Trial.
abstract: Review of "Long term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial" by Davies et al. (2013), Lancet, 381, 805-816. For another perspective on the ATLAS trial, please see the article on randomization and adjusting for covariates by Dustin Dickerson starting on page 61.
authors.affiliation: University of Michigan, Ann Arbor, Michigan.
authors.forename: G Lita
authors.initials: GL
authors.lastname: Smith